Vonafexor
Vonafexor (EYP001) is a selective FXR agonist with anti-HBV effects. (In Vitro) :Vonafexor (EYP001) inhibits the HBV replication cycle in HepaRG cells resulting in significant reductions in HBV DNA, HBsAg and HBeAg secretion, with additive effects when combined with Entecavir (HY-13623) or Tenofovir (HY-13910) .
Product Specifications
CAS Number
1192171-69-9
Product Name Alternative
EYP001
Purity
>98% (HPLC)
Solubility
DMSO : 83.33 mg/mL (170.14 mM; Need ultrasonic)
Smiles
O=C (C1=CC2=C (Cl) C (N3CCN (S (=O) (C4=C (Cl) C=CC=C4Cl) =O) CC3) =CC=C2O1) O
Molecular Formula
C??H??Cl?N?O?S
Molecular Weight
489.76
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
K6013605 3x 1.0 µg
LOC685046 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Rat)
Sign In for Pricing
View Details 250960-FITC 100 µL
RBMS2 (RNA Binding Motif, Single Stranded Interacting Protein 2, FLJ39093, FLJ40023, FLJ43262, SCR3) (FITC)
Sign In for Pricing
View Details RPU41532-01 50 µg
Recombinant Human Cluster Of Differentiation 15 (CD15)
Sign In for Pricing
View Details